Anebulo Pharmaceuticals (ANEB) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist

1.620
+0.370+29.60%

Close Dec 24 13:00 ET

1.410
-0.210-12.96%

Post 16:58 ET

42.01MMarket Cap-5.40P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BenzingaDec 24 16:06 ET
Anebulo Pharmaceuticals Collaborates With FDA to Advance Selonabant
TipRanksDec 23 09:25 ET
Express News | Anebulo Pharmaceuticals: Intends to Modify Loan and Security Agreement by Reducing Maximum Loan Size to About $3 Mln
ReutersDec 23 09:17 ET
Express News | Anebulo Pharmaceuticals: Entered Stock Purchase Agreement for Issuance & Sale of 15.2 Mln Shares of Common Stock for $15 Mln
ReutersDec 23 09:16 ET
Anebulo Pharmaceuticals Announces FDA Feedback For IV Selonabant To Address Cannabis-Induced Toxicity In Children And Completes $15M Capital Raise; Phase I Study Planned For 1H25
BenzingaDec 23 09:16 ET
Express News | Anebulo Pharmaceuticals Inc: Plans to Begin Its Phase I Sad Study of IV Selonabant in Healthy Adults in 1H25
ReutersDec 23 09:15 ET

Comments

Jaguar8

Dec 23 16:05

$Anebulo Pharmaceuticals (ANEB.US)$
On December 22, 2024, Anebulo Pharmaceuticals, Inc., a Delaware corporation (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with 22NW Fund, LP (“22NW”), a greater than 5% stockholder of the Company that is controlled by Aron English, a director of the Company, as well as other institutional accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell to the Investors, in a private place...

Jaguar8

Dec 23 08:15

NEWS

$Anebulo Pharmaceuticals (ANEB.US)$
Anebulo Pharmaceuticals Announces Positive Regulatory Update for Selonabant in Acute Cannabis-Induced Toxicity in Children and Capital Raise
Monday, 23rd December at 9:15 am
Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid-induced toxicities (the "Company" or "Anebulo"), today announced a positive regulatory update and the close of a capital raise....

Arrayfunction

Oct 18 17:48

Starting to see how day trading can fall into the trap of gambling addiction with short selling!

Let's see if I can manage to avoid losing it all and then some next week!
After relying on just gut feeling to dump heavy into Netflix before the earnings and go to sleep.....while setting to the limit orders to sell between 720 and 730, definitely felt a bit dense
Thought I would have my revenge by shorting the peak! I've never put enough of my assets into trading to short sell (in the US, you ne...